Status:
COMPLETED
RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Primary Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators are studying motivational interviewing (MI). MI is a counseling method to help people adopt healthy behaviors. The investigators will test whether MI improves patients' accurate use ...
Eligibility Criteria
Inclusion
- community-dwelling adults with primary or secondary open-angle glaucoma, and
- a current prescription for monotherapy topical glaucoma medication.
Exclusion
- patient-reported inability to administer eye drops that cannot be addressed successfully through in-person instruction at the clinic,
- cognitive impairment at a level that would in the judgment of the referring physician interfere with study participation,
- referring physician's determination that glaucoma surgery is likely within the next 6 months,
- any active medical, psychological, or substance use disorder that would in the referring physician's judgment significantly interfere with study participation (e.g., comorbid congestive heart failure (CHF) resulting in a recent hospitalization; active psychosis due to uncontrolled bipolar disorder; etc.), or
- no visual field test within the past 6 months (data required for the randomization approach described below).
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT01409421
Start Date
April 1 2011
End Date
January 1 2013
Last Update
October 1 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lions Eye Institute, UC Denver
Aurora, Colorado, United States, 80045
2
Devers Eye Institute
Portland, Oregon, United States, 97210